In the same study, it was observed that cisplatin is able to raise the population of CD133-positive cancer stem-like cells which are then targeted by CD133 CAR-T cells, so this combination could improve gastric cancer prognosis (Table 1) [24]. Here, PROM1 is linked to gastric cancer.